However, many anti-obesity agents that have entered human clinical trials have shown unacceptable adverse events
Go low and slow Incretin-based medicines are typically started at a minimum dose, and the dose increases each month or so
Simply select your parameters, and our calculator will give you the results
Frontiers in Public Health, 10, 996179
Benjamin Duffy, an Obesity Medicine Specialist at ThedaCare, emphasizes that a provider-guided tapering process typically takes about two months
Our experienced medical providers carefully evaluate each patients medical history, treatment goals, preferences, and potential side effects when recommending the most suitable GLP-1 receptor agonist